Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics interviews Holly Krasa, CEO of Blue Persimmon Group. In this episode they discuss the recent CPE Exclusive: Cobenfy™ for Adults Living with Schizophrenia, the need for innovation in schizophrenia, and the importance of listening to the stories from people living with schizophrenia.
